Researchers at the University of Pennsylvania have introduced lab-engineered small extracellular vesicles to target tumors in ...
After a Stage 4 cancer diagnosis and a prognosis of 16 months to live, Katie Doble didn’t know whether she should plan her ...
Researchers have developed a new method for growing T cells in the lab, allowing them to survive longer and fight cancer more effectively. This advancement, detailed in Cell Metabolism, could ...
An approach using engineered small extracellular vesicles from NK cells to DR5 could be a promising strategy for solid tumors ...
Dr. Balazs Halmos discusses the significance of the approval of subcutaneous Opdivo and what this treatment formulation means ...
A person's lifetime risk for cancer may begin before they are even born, reports a paradigm-shifting study. The findings identified two distinct epigenetic states that arise during development and are ...
Professor Meghan Morrissey earns an innovation award to program immune cells to attack cancer tumors. #immunotherapy ...
A Bay Area biotech is suing its insurance company to cover costs associated with patients allegedly injured during clinical ...
Preliminary findings from the phase 1 trial showed that GCC19CART, a novel CAR T-cell therapy, demonstrated clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback